Výsledky vyhledávání - "di Toritto TC"

Report

Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment.

Autor: Paciaroni K; UOSD Ematologia, ASL Roma 1, Roma, Italy., Sangiorgi E; Istituto di Medicina Genomica, Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy., Pulvirenti F; Reference Centre for Primary Immune Deficiencies, Policlinico Umberto I, Rome, Italy., Villiva N; UOSD Ematologia, ASL Roma 1, Roma, Italy., Andrizzi C; UOSD Ematologia, ASL Roma 1, Roma, Italy., Campagna S; UOSD Ematologia, ASL Roma 1, Roma, Italy., Tordi A; UOSD Ematologia, ASL Roma 1, Roma, Italy., Celesti F; UOSD Ematologia, ASL Roma 1, Roma, Italy., Manna R; Istituto di Medicina Interna, Rare diseases and periodic Fevers Research Center, Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy., Gurrieri F; Operative Research Unit of Medical Genetics, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Licci S; Istituto di Medicina Interna, Rare diseases and periodic Fevers Research Center, Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy.; Pathology Unit, San Filippo Neri Hospital, Rome, Italy., di Toritto TC; UOSD Ematologia, ASL Roma 1, Roma, Italy.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (14), pp. 2343-2346. Date of Electronic Publication: 2023 Sep 12.

Zobrazit plný text záznamu

Editorial & Opinion

A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma.

Autor: Rago A; Haematology Unit, ASL ROMA 1, Rome, Italy. angela.rago@aslroma1.it., Palumbo G; Department of Translational and Precision Medicine, Haematology, A.O.U Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Tordi A; Haematology Unit, ASL ROMA 1, Rome, Italy., Bianchi S; Department of Translational and Precision Medicine, Haematology, A.O.U Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Offidani M; AOU delle Marche, Ancona, Italy., di Toritto TC; Haematology Unit, ASL ROMA 1, Rome, Italy.

Publikováno v: Annals of hematology [Ann Hematol] 2023 Oct; Vol. 102 (10), pp. 2977-2978. Date of Electronic Publication: 2023 Jul 11.

Zobrazit plný text záznamu

Akademický článek

Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.

Autor: Pepe S; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Via Benevento 6, 00161, Rome, Italy., Rossi E; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy., Trawinska M; Ospedale S. Eugenio, Rome, Italy., Tatarelli C; Hematology, Department of Clinical and Molecular Medicine, University Hospital Sant'Andrea, Sapienza University of Rome, Rome, Italy., Di Veroli A; Belcolle Hospital, Viterbo, Italy., Maurillo L; Tor Vergata University, Rome, Italy., Romano A; Hematology, IFO, Rome, Italy., Crescenzi SL; S. Giovanni Addolorata Hospital, Rome, Italy., di Toritto TC; UOSD Ematologia ASL, Roma 1, Rome, Italy., Tafuri A; Hematology, Department of Clinical and Molecular Medicine, University Hospital Sant'Andrea, Sapienza University of Rome, Rome, Italy., Latagliata R; Belcolle Hospital, Viterbo, Italy., Scalzulli E; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Via Benevento 6, 00161, Rome, Italy., Andriani A; Spaziani Hospital, Frosinone, Italy., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy., Breccia M; Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Via Benevento 6, 00161, Rome, Italy. breccia@bce.uniroma1.it.

Publikováno v: Annals of hematology [Ann Hematol] 2022 Jun; Vol. 101 (6), pp. 1275-1282. Date of Electronic Publication: 2022 Mar 22.

Zobrazit plný text záznamu

Akademický článek

Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.

Autor: Vozella F; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy. federico.vozella@gmail.com., Siniscalchi A; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Rizzo M; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Za T; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Antolino G; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Coppetelli U; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Piciocchi A; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Andriani A; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Annibali O; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., De Rosa L; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Cimino G; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., La Verde G; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., De Stefano V; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Cantonetti M; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., di Toritto TC; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy., Petrucci MT; Multiple Myeloma GIMEMA Lazio Group, Via Casilina 5, 00182, Rome, Italy.

Publikováno v: Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1059-1063. Date of Electronic Publication: 2021 Feb 02.

Zobrazit plný text záznamu

Akademický článek

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies.

Autor: Bringhen S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino sarabringhen@yahoo.com., Mina R; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino., Petrucci MT; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara., Ballanti S; Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia di Perugia, Perugia., Musto P; Unit of Haematology and Stem Cell Transplantation, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture., Offidani M; Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona., Spada S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino., Benevolo G; Hematology, Città della Salute e della Scienza, Turin., Ponticelli E; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino., Galieni P; Division of Hematology, Ospedale 'C. e G. Mazzoni', ASUR Marche-AV5, Ascoli Piceno., Cavo M; 'Seràgnoli' Institute of Hematology, Bologna University School of Medicine, Bologna., Di Toritto TC; UOC Ematologia, Ospedale S. Eugenio, ASLRM2, Rome., Di Raimondo F; Division of Hematology, AOU Policlinico-OVE, University of Catania, Catania., Montefusco V; Hematology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Palumbo A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino., Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino., Larocca A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino.

Publikováno v: Haematologica [Haematologica] 2019 Aug; Vol. 104 (8), pp. 1640-1647. Date of Electronic Publication: 2019 Feb 07.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání